At a meeting of The American Society of Hematology on Sunday, researchers from the University of Pennsylvania presented their findings on what very well could be a genetic therapy cure for cancer.

The concept utilizes a disabled form of HIV that genetically alter the patients own T cells to attack malignant B cells. Providing the patient with something better than a drug–a lasting way for the immune system to fight cancer.

University of Pennsylvania researchers developed the experimental treatment that has been tested on 12 patients,